Global Chicken Meat Market is expected to expand with a nominal CAGR of 0.96% during 2021-2027

According to Renub Research report titled, “Global Chicken Market, Size, Share, Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis” The Worldwide Chicken Market Size was USD 196.02 Billion. The chicken market has increased, consolidation, and globalized in multiple countries of all income levels, mainly owing to strong demand. The major producers are likely to achieve significant advances, with the United States, Brazil, and China leading the way. Globally, the chicken industry is most dynamic and adaptable in the worldwide livestock market. Furthermore, the chicken, which was formerly considered a unique treat, is today the most devoured animal on the planet. The chicken meat industry plays a vital role in nutrition and is the fastest-growing agricultural sub-sector, particularly in emerging countries.

Global Chicken Market to Reach USD 207.67 Billion by 2027

The Chicken Market will grow at a nominal growth rate:

The chicken industry is one of the most competitive markets in the world, and it is presently mature. Besides, consumer awareness of animal-rich protein has increased significantly in the last few years. Moreover, chicken meat is becoming increasingly popular among people in both developed and developing countries, and it is expected that this trend will continue in the future years. As a result, the market has been growing nominally with considerable growth rates over the last few years, anticipating to increase significantly in the forecast period, i.e., 2021-2027. Furthermore, many companies are generating clean meat in laboratories employing cell technology, which avoids the use of animal slaughter. As per our analysis, during 2021-2027, the Global Chicken Market market is predicted to grow at a CAGR of 0.96%.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=global-chicken-market-p.php

China, the United States, and Brazil are the Largest Producers of Chicken:

Over the period of time, global chicken production has seen upsurge records in various countries such as European Union, Russia, China, Brazil, India, Argentina, Turkey, Columbia, Mexico, Thailand, and the United States. As per our report, the United States, Brazil, China are the leading chicken producers worldwide. Several companies and manufacturers worldwide have taken steps to introduce cell-based chicken meat, which is gaining popularity in the market. For instance, as published on March 1, 2021, in CNBC, Eat Just, a multibillion-dollar company, is selling lab-grown chicken worldwide. Aside from that, the nutritional benefits of chicken meat products are well-known around the world.

China, Thailand, and the European Union have Significant Consumption Markets:

In our report, we have analyzed the consumption market of chicken in Brazil, China, the European Union, India, Russia, Mexico, Thailand, Argentina, Columbia, Turkey, and the United States. Remarkably, the United States, China, and Brazil are the leading chicken-consuming countries in the world. Moreover, we have accessed that China had the most impressive consumption growth rate in terms of poultry consumption per capita among the leading consumer countries. In contrast, other global leaders’ poultry consumption per capita grew considerably slower.

Importing and Exporting Countries of the Chicken:

We have covered Mexico, Japan, China, European Union, Saudi Arabia, United Arab Emirates, South Africa, Iraq, the Philippines, and United Kingdom. As per our analysis, Japan, Mexico, and United Kingdom are the major importing countries. Further based on our report, we have analyzed the export market of the European Union, Brazil, Ukraine, Thailand, China, Turkey, Belarus, Argentina, Russia, and the United States. Remarkably, Brazil, the United States, and European Union are the leading exporters.

Key Players

Our report includes JBS S.A., Tyson Foods, Pilgrim’s Pride Corporation, Danish Crown Group, Vion Food Group, WH group, Hormel Foods Corporation, Muyuan Foods, among the key market players. Further, our analysis includes a business overview, sales analysis, and recent development of the companies.

COVID-19 Impact on the Global Chicken Industry

During the pandemic, chicken sales in the first few months were regularly declining as rumors spread that COVID-19 could be transmitted through meat consumption. However, as per our analysis, the chicken market will rebound in the forecast period, i.e., 2021-2027. Production and transportation disruptions, dwindling consumer demand, and fluctuating markets wreaked havoc on farm finances, forcing many to close permanently. The distribution of chicken and poultry products was hampered by market risks such as value chain fragmentation, high intermediation costs, and no or limited traceability. Hence, the global chicken market saw a negative impact during the pandemic.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/global-chicken-market-p.php

Market Summary:

  • Production: We have covered chicken production in China, Brazil, European Union, Russia, India, Mexico, Thailand, Argentina, Turkey, Columbia, United States.
  • Consumption: Our report includes China, Brazil, the European Union, Russia, Mexico, South Africa, Japan, Argentina, the United Kingdom, Thailand, and the United States as consuming countries of the global chicken market.
  • Import: In our report, we have covered Japan, Mexico, China, European Union, United Arab Emirates, Saudi Arabia, Iraq, South Africa, the Philippines, and United Kingdom as importing countries.
  • Export: We have covered chicken export in Brazil, European Union, Thailand, Ukraine, China, Turkey, Belarus, Russia, Argentina, and the United States.
  • Key Players: Our report includes companies like JBS S.A., Tyson Foods, Pilgrim’s Pride Corporation, Danish Crown Group, Vion Food Group, Hormel Foods Corporation, WH group Muyuan Foods as key market players in the global chicken industry.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

Global Adult Vaccine Industry is projected to grow with a CAGR of 6% from 2021-2027

According to Renub Research report titled, “Adult Vaccine Market, Size, Global Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis” the Global Adult Vaccine Market is estimated to reach USD 18.8 Billion by 2021. Over the years, vaccine-preventable diseases have been killing thousands of adults each year worldwide. Vaccines, surprisingly, are used to prevent infections and boost the body’s immunity. Hence, adult vaccination has become one of the most cost-effective public health interventions accessible today. Moreover, it is also a biological preparation that comprises an agent that looks like a disease-causing germ created from weakened and destroyed microorganisms.

Global Adult Vaccine Market to Reach US$ 26.7 Billion by 2027

Global Adult Vaccine Industry Is Projected to Grow with A CAGR of 6% From 2021-2027:

Some of the major drivers for the global adult vaccines market are increased illness prevalence and novel vaccination technologies. Furthermore, increased research in the field of vaccine technology and increasing government backing are all contributing to the global adult vaccines market’s growth. Several government agencies are funding and granting research on customized vaccinations to improve their efficacy and disease-prevention potential.

In addition, some government organizations are putting in place particular requirements for their safe practices. Increased R&D investment by pharmaceutical and biopharmaceutical companies and widespread R&D pipelines are expected to help move the worldwide adult vaccines market forward.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=adult-vaccines-market-company-adult-vaccines-sales-country-adult-vaccines-worldwide-analysis-19-p.php

Disease wise – Adult Vaccines Market & Numbers of Adults Vaccinated:

In our report, Coronavirus (COVID-19), Influenza, Cervical Cancer (HPV), Zoster (Shingles), MMR (Measles, Mumps, and Rubella Vaccine), Pneumococcal, Meningococcal, Hepatitis, TdaP, and Varicella are the diseases included. Furthermore, due to the growing negative worries about prevalent infectious diseases, which are the leading causes of mortality and morbidity worldwide, the number of immunizations for various diseases is at an all-time high.

Further, the worldwide number of adult vaccines vertical has seen significant expansion due to the continual increase in demand for immunization against severe diseases such as cholera, typhoid, hepatitis, measles, chickenpox, and many others. On the other hand, several molecular entities are through substantial research and development stages and are aimed at immunizing against deadly diseases.

Key Players in the Global Adult Vaccine Industry:

The significant companies studied in the global adult vaccine market include GlaxoSmithKline, plc, Merck & Co.’s, Sanofi Pasteur’s, Pfizer, Inc.’s, and Thoracic Aortic Aneurysm (TAA) CSL Limited’s. As per our analysis, the key players are focusing on business expansion to increase their revenue share by implementing mergers and acquisitions and new product development strategies. For instance, GlaxoSmithKline plc announced in 2021 that they had submitted a (BLA) Biologics License Application to the US Food and Drug Administration for their investigational vaccine PRIORIX, requesting authorization to use it against measles, mumps, and rubella (MMR) in the United States. The vaccine was first registered in Germany and is now approved in more than 100 countries worldwide.

COVID-19’s Impact on the Global Adult Vaccine Market:

The COVID-19 pandemic had a diverse impact on the global adult vaccine industry. Vaccination rates for some vaccines have decreased. On the other hand, vaccination rates for a few vaccines, such as flu vaccines, have increased. The introduction of COVID-19 vaccines has significantly impacted the vaccine industry’s overall growth. Furthermore, we aim to see the global adult vaccines market to quantify the health, economic, and social benefits of vaccines and immunization programs to individuals and society.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/adult-vaccines-market-company-adult-vaccines-sales-country-adult-vaccines-worldwide-analysis-19-p.php

Market Summary:

  • Disease Wise: We have analysed the market for Influenza, Cervical Cancer (HPV), Zoster (Shingles), MMR (Measles, Mumps, and Rubella Vaccine), Pneumococcal, Meningococcal, Hepatitis, TdaP, Travel and Miscellaneous, Varicella)
  • Numbers of Vaccinated Adults: We have covered the numbers of vaccinated adults for Influenza, Meningococcal, Cervical Cancer (HPV), MMR (Measles, Mumps, and Rubella Vaccine), Pneumococcal, Zoster (Shingles), Hepatitis, TdaP, Varicella.
  • Company Analysis: The key players covered in our report are GlaxoSmithKline, plc., Merck & Co., Sanofi Pasteur’s, Pfizer, Inc., Thoracic Aortic Aneurysm (TAA) CSL Limited.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

Global Battery Market to Grow with a CAGR of 9.2% from 2022-2027

As per the latest report by Renub Research titled “Battery Market by Transport, Size, Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” the Battery Market by Transport Size will reach USD 158.41 Billion by 2027. A transportation battery is an electric battery utilized in all-electric vehicles. Transportation batteries rely solely on the chemical energy stored in rechargeable battery packs and do not need a secondary source of propulsion (internal combustion engine, hydrogen fuel cell, and others). The development and commercialization of energy storage technology will significantly impact the power system; because of rapid growth and expansion from small scale towards large scale. It has been durable for more than ten years. Transportation batteries have a wide range of applications like electric trucks, electric vans, rail, electric buses, electric cars, electric motorcycles, scooters, and rickshaws.

Worldwide Battery Market Size by Transport was valued at USD 86.24 Billion in 2021

Notwithstanding, the growing integration of electronics and the rising demand for transportation are the driving factors for the transportation battery industry. Likewise, fuel savings & government incentives for cleaner transportation are essential factors that can boost the growth of the transportation battery market. Furthermore, the introduction and innovation of new hybrid & electric automotive models from OEMs are anticipated to capture the transportation battery market, serving as a stepping stone for market growth.

COVID-19 Impact on Battery Market by Transport

During the pandemic, lithium cell manufacturing plants were temporarily stopped, resulting in a lithium supply shortage in various industries, negatively affecting the transportation battery market. Similarly, the cost of lithium hydroxide, which is utilized in Electric Vehicles (EVs), has grown due to the impact of COVID-19, which has resulted in logistical problems and a rise in the production price as a result of the outbreak. Trade restrictions imposed by the COVID-19 pandemic hindered the supply chain of components such as cobalt and lithium, which are necessary for the manufacturers affecting the transportation battery market growth.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=global-battery-market-by-transport-p.php

The Lead-Acid Battery is anticipated to have Significant Growth

Based on Battery Type, transportation battery includes Lithium-ion Based, Lead-acid Based, Nickel-Based, Sodium-ion, and others. The lead-acid battery is rising significantly worldwide. Some of the aspects that surge the need for lead-acid batteries are increase in renewable energy production, developing SLI applications in the automotive industry, and increased demand for energy storage devices. Lead-acid batteries are widely used in the transportation industry, as countries embrace electric vehicles to reduce carbon emissions. The need for lead-acid batteries in the transportation industry is developing rapidly, as emerging economies’ governments support environmentally friendly modes of transport and clean energy.

Besides, the market for lithium-ion batteries is expected to observe the fastest growth during the coming year. A lithium-ion battery is equipped for automotive, consumer electronics, energy storage systems, industrial, and others that demand high-energy density solutions such as electric automobiles and hybrid. Further, to increase vehicle economies, manufacturers are continuously focusing on reducing the price of the battery, driving the market growth globally.

Automotive Battery is the largest segment in Battery Market by Transport

On the basis of Vehicle Type, transportation battery segmented into Automotive Battery, E-bikes, Marine, Forklift. The automotive battery is anticipated to witness steady growth during the forecast period due to the growing preference of end-users for zero-emission hybrid and electric vehicles, owing to the falling battery price, decreasing crude oil reserves, and environmental effects of conventional automobiles. In accumulation to this, a rises in the global battery production capacity has enabled achieve economies of scale in the automotive battery market, which is another primary driver for market growth.

Furthermore, an automotive battery is a rechargeable battery, and it supplies electrical current to a motor vehicle. The batteries are mainly utilized for lighting, powering starting, and ignition of a vehicle. Apart from this, automotive battery is also used to provide power to automobile accessories such as music players, air conditioners, radio, wipers, and charging plugs.

Asia-Pacific to Witness Considerable Growth

Geographically, the Asia Pacific is the biggest automotive battery market, followed by the Americas, Europe, and the Middle East and Africa. The growth rate is largest in the Asia Pacific and is anticipated to be even higher during the forecasted period. Such an increased growth rate is attributed to the emergence of China as a international hub for the automobile industry and rising demands for vehicles from some of the other Asian countries such as Indonesia, Malaysia, India, Thailand and the Philippines.

On the other hand, India and China are to be adequate investment hotspots for battery companies in the coming years, based on policy-level support from the respective governments boosting the manufacturing sector. The deployment of electric vehicles and the building of renewable power plants in China and India are growing rapidly, fostering massive demand for batteries.

Competitive Outlook

The major players in the transportation battery market consist of GS Yuasa Corporation, Johnsons Controls Inc, BYD Company Ltd., Samsung SDI Company Limited, Exide Technologies. The companies are tying up with car companies to increase their market share.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/global-battery-market-by-transport-p.php

Market Summary:

  • Battery Type – Renub Research Report covers by Battery Type in the 5 viewpoints (Lithium-ion Based, Lead-acid Based, Nickel-Based, Sodium-ion and others)
  • Vehicle Type – We have covered Battery Market by Transport breakup by 4 viewpoints by Vehicle Type (Automotive Battery, E-bikes, Marine and Forklift)
  • Region – Our Report have covered Battery Market by Transport breakup by 4 viewpoints by Region (Americas, Asia-Pacific, Europe and Middle East and Africa)
  • All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) GS Yuasa Corporation, Johnsons Controls Inc, BYD Company Ltd., Samsung SDI Company Limited, Exide Technologies.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

Canada Fast Food Industry is expected to expand at a CAGR of 4.7% from 2021-2027

According to Renub Research report titled, “Canada Fast Food Market, Share, Insight, Forecast 2022-2027, Industry Trends, Growth, Size, Impact of COVID-19, Company Analysis” Canada Fast Food Market Size was USD 31.8 Billion in 2021. The Canadian food industry has evolved and changed to meet customer demands and consumer behavior. Remarkably, food is prepared and served at independent fast-food restaurants, street vendors, or chained fast-food restaurants such as Tim Hortons, Starbucks, McDonald’s, Dairy Queen, KFC, Dominoes, Pizza Hut, Wendy’s, and Burger King is referred to as fast food.

Besides, they can be used as a substitute for home-cooked meals. According to BC Food Web, fast food accounted for 6.3 percent of the average Canadian’s daily food intake in 2020. As a result, fast food has established roots in both developed and developing economies over time, and it is primarily accepted due to its quick availability and taste factor.

COVID-19’s Impact on the Canadian Fast Food Industry:

The COVID-19 pandemic harmed Canada’s fast-food industry due to increased cases and fears of infection from food. Furthermore, revenue has been impacted by operational disruptions in the hotel and food & beverage industries and disturbances in the supply chain provoked by the COVID-19 outbreak. During the pandemic, increased awareness of the benefits of eating healthy foods influenced market growth. Regardless, due to an increase in the number of fast-food franchises and growing demand for online food deliveries, the market regained its demand following the pandemic.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=canada-fast-food-market-p.php

Canada Fast Food Industry Is Anticipated to Expand At A CAGR Of 4.7% From 2021-2027:

The major factors propelling the market expansion are increased consumer spending and the growing influence of food delivery applications. Furthermore, faster urbanization and globalization are attributed to the increase in restaurants and hotels, which is expected to boost the Canadian fast-food market’s growth. Again, because women do not have enough time to prepare meals, they turn to fast food and use technology to order, which fuels the development of the Canadian fast-food market. Additionally, increased media and travel exposure to international cuisine will continue to drive the growth of this market.

Burgers/Sandwiches and Pizza Are the Most Favored Fast Food in Canada:

Depending on the type, the market revolves around pizza/pasta, burgers/sandwiches, chicken, Asian/Latin American food, and seafood. Due to the flavors and ingredients used in the products, burgers/sandwiches have been the most popular fast food among consumers. The vast availability of burger options, including products with protein options such as venison, beef, and several others, can be attributed to the growing demand for burgers/sandwiches.

Furthermore, several food-service operators experimented with various cheese, bacon, onion, meatloaf, and other fillings. Nonetheless, pizza/pasta is the most popular fast food in Canada, owing to increased consumer demand for taste and preferences, and pizza is the most popular takeout and delivery option. During the Canadian fast-food market forecast, it is expected to grow at a phenomenal rate.

Service That Is Quick Restaurants Are the Most Popular Medium Among Canadians:

As per our analysis, in Canada, the Fast Food Market, the end-user industries such as Quick Service Restaurants (QSRs), Street Vendors, Home Delivery, Cafés, and Bars, among others, use fast food extensively. Consumers in Canada prefer quick-service restaurants, driving up demand for fresh, tasty, and appealing food at a reasonable price. As a result, the demand for quick-service restaurants is growing. Besides, during the pandemic, the home delivery option has seen a lot of growth. Wherein, the plurality of consumers chooses to order online while staying indoors.

Competitive Landscape:

In our report, Starbucks Corp, Domino’s Pizza Inc, The Wendys Co., Kentucky Fried Chicken (KFC), Tim Hortons, Restaurant Brands International Inc, A&W Food Services of Canada Inc, MTY Food Group Inc, Papa John’s International Inc, Performance Food Group Company are all analyzed to be strong players in the Canada Fast Food Market. The market’s major players have extensive global distribution networks. Furthermore, businesses are improving their menus and services in response to shifting consumer preferences. Moreover, an increase in the number of quick-service restaurants in the industry is aiding sales.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/canada-fast-food-market-p.php

Market Summary:

  • Type: We have covered Independent Consumer, Chained Consumer in our market analysis.
  • Cuisines Type: In our report we have studied the market for Pizza/Pasta, Burgers/Sandwiches, Chicken, Asian/Latin American food, and seafood
  • End User: We have covered Quick Service Restaurant (QSR), Street Vendors, Home Delivery, Cafés, and bars and other as market for end-users in Canada Fast Food Market.
  • Company Analysis: The key players covered are Starbucks Corp, Domino’s Pizza Inc, The Wendys Co., Kentucky Fried Chicken (KFC), Tim Hortons, Restaurant Brands International Inc, A&W Food Services of Canada Inc, MTY Food Group Inc, Papa John’s International Inc, Performance Food Group Company

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

United States Anesthesia Drugs Market will grow with a CAGR of 4% from 2021-2027

As per the latest report by Renub Research titled “United States Anesthesia Drugs Market, Size, Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” United States Anesthesia Drugs Market Size was US$ 4.9 Billion by 2027. In the United States, anesthesia drug is one of the milestones in the pharmaceutical industry, which benefits patients with painless treatment and impossible to perform surgery. The US is home to bigwigs in the pharmaceutical sector to increase their stakes in the United States market. Anesthesia meant the condition of holding sensation blocked or temporarily taken away. This authorizes the patient to undergo surgery and other procedures without distress and pain they would otherwise experience. Anesthesia drugs are used while performing surgical procedures to control pain, heart rate, blood pressure, breathing, rhythm, and blood flow.

Top Impacting Factors:

Notwithstanding, the United States anesthesia drug market is driven by the rising number of surgeries, the growing aging population with increasing chronic conditions, and advancements in anesthesia technologies. As per the statistics provided by the (ASPS) American Society of Plastic Surgeons, in 2019, nearly 16.3 Million cosmetic minimally-invasive procedures and 1.8 Million cosmetic surgical were performed in the United States.

Request a Free Sample Copy of the Report:  https://www.renub.com/request-sample-page.php?gturl=united-states-anesthesia-drugs-market-and-forecast-31-p.php

Furthermore, the demand for various anesthetics goes hand-in-hand with the performed surgical procedures. The application of anesthetics in general surgeries is anticipated to contribute significantly to the market’s growth in the United States. Further, new anesthesia drugs are being developed, which is predicted to propel market growth. For instance, in 2020, Medova and the New York School of Regional Anesthesia (NYSORA) entered a partnership to introduce SAFIRA (SAFer Injection for Regional Anesthesia) in the United States.

COVID-19 Impact on Anesthesia Drugs Industry:

In the United States, the demand for anesthesia drugs seen a slight drop in 2020 due to the emergence of the pandemic situation, cancelled surgeries or leading to delayed. With the emergence of COVID-19, the United States faced extreme shortages of vital anesthesia drugs, mainly canceled surgeries, dexmedetomidine, midazolam, Propofol, and neuromuscular blocking agents. Most of the surgeries were delayed, and only acute surgical emergencies were managed. Thus, the COVID-19 has an unfavorable impact on the United States anesthesia drugs industry. As a result, numerous players are ramping up their production of anesthesia drugs. For instance, in 2020, Hikma Pharmaceutical introduced a new product, “Propofol Injectable Emulsion,” in the United States.

General Inhalation Anesthesia is the Leading Segments in the United States Anesthesia Market

Based on type, the United States anesthesia drugs market includes the General Inhalation Anesthesia Drugs market, General Intravenous Anesthesia Drugs Market, and Local Anesthesia Drugs Market. General Inhalation Anesthesia Drugs Market holds a considerable market share; the inhaled anesthetics include desflurane, isoflurane, sevoflurane, and others that enhance inhibit excitatory synaptic activity and inhibitory postsynaptic channel activity. General intravenous anesthesia drugs are less costly and do not need expensive machines for administration. Moreover, intravenous anesthesia drugs result in undersized cardiovascular depression and better postoperative analgesia.

Besides, general intravenous anesthesia is the leading segment in the United States Anesthesia Market. Fospropofol Disodium, Propofol, Benzodiazepines Class, Ketamine, Methohexital Sodium, Pentobarbital, Etomidate, and Fentanyl are generally utilized general intravenous anesthesia in the United States. Propofol drug is one of the most frequently used general anesthetics in surgeries among these anesthesia drugs. It is utilized as a sedative for critical care (including COVID-19) in the ICU. It is used to maintain procedural sedation, initiate general anesthesia, etc. In  2020, the United States (FDA) Food & Drug Administration approved the usage of Fresenius Propoven 2% emulsion to maintain sedation in COVID-19 patients (16 years and above) requiring mechanical ventilation.

Competitive Landascape

The United States anesthesia drugs market is highly competitive and consists of several major players. Most of the anesthesia drugs trade is generic and are available at a low cost. The key players include Draegerwerk AG, Abbvie, Baxter International Inc., Endo International plc, and Koninklijke Philips NV.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/united-states-anesthesia-drugs-market-and-forecast-31-p.php

Market Summary:

  • Types – Renub Research Report covers United States Anesthesia Drugs Market by type in the 3 viewpoints (General Inhalation Anesthesia Drugs market, General Intravenous Anesthesia Drugs Market and Local Anesthesia Drugs Market)
  • United States Anesthesia Drugs Market – This has been further break-up in 8 segments: Propofol, Benzodiazepines Class (Diazepam and Midazolam), Fospropofol Disodium, Ketamine, Methohexital Sodium, Pentobarbital, Etomidate, Fentanyl
  • United States General Inhalation Anesthesia Drugs Market – This has been further break-up in 4 segments: Sevoflurane, Desflurane,   Isoflurane, Others
  • United States Local Anesthesia Drugs Market – This has been further break-up in 7 segments: Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine, Other Local Anesthetics
  • All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Draegerwerk AG, Abbvie, Baxter International Inc., Endo International plc, and Koninklijke Philips NV.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

Worldwide Online Education Industry is expected to grow with a double-digit CAGR of 13.8% during 2021 -2027

As per the latest report by Renub Research titled “Online Education Market, Size, Global Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” the Global Online Education Market Size was USD 585.48 Billion in 2027. Recently, online education has become an essential part of the modern education system. Online education is an electronically supported learning framework, which depends on the internet for cooperation and appropriation of study material among understudies and instructors. Many drivers drive the Online Education Market. It offers both the students and teachers an efficient way to transfer knowledge by the mode of videos, PDFs, podcasts, etc., which are beyond the scope of paper and pen. It also offers accessibility of time and place, which helps the schools and other educational universities access, many other students.

Online education platforms are more affordable than general pen and paper models and are easy on the environment. Nonetheless, developing interest to decrease the expense of instruction, expanding government drives supporting online schooling, and growing infiltration of cell phones and the internet are the variables adding to the growth of the online education market. Similarly, the market growth is anticipated to be facilitated, attributing to the expanding interest for versatile and adaptive learning and the emergence of an AI-enabled e-learning solution.

COVID-19 Impact on Online Education Market

With the rise of the COVID-19 cases, all colleges, schools, and other learning institutes were closed due to the lockdown implemented to avoid the spread of the coronavirus. This fuled the growth of online education platforms as academic institutes embraced e-learning mediums to provide training and education for individuals during the COVID-19 executed lockdowns. In 2020, according to UNESCO (United Nations Educational, Scientific and Cultural Organization), over 1.2 billion students in 186 countries were impacted by school closures due to the COVID-19 pandemic. Countries that are worst smacked by the coronavirus have seen unprecedented growth in distance education enrollments.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=online-education-market-p.php

Academic Institutions hold a Significant Market Share

On the basis of user’s type, the online education market is segmented into government, academic and corporate. With the rising number of students in academic organizations and the regular need to upskill and provide industry-relevant training to the staff, academic institutions and corporations need to develop options that allow individuals to learn anytime from anywhere. Increased effectiveness of animated learning and flexibility in learning are other factors contributing to academic institutions’ growth of online education. Lack of competent staff in various colleges and schools across the developing nations also results in the adoption of online schooling by the students. Support and government funds are other primary drivers for academic institutions’ growth of online education.

Online Mobile e-learning is the Fastest-Growing Technology Segment

By technology, online e-learning delivers knowledge to students through electronic modes such as audio, e-books, videos, AR/VR, or any other electronic method. Online e-learning technology provides various benefits to the students, including low cost of education and specialized course learning. Additionally, online e-learning has become an integral part of the majority of institutions as it enhances the performance of employees. For instance, according to IBM statistics, e-learning can increase productivity by 50% by using online e-learning software to provide employees with an amazing opportunity to engage in their training courses at any suitable time. Apart from this, mobile e-learning is the fastest-growing technology segment due to increasing income levels, and then those dollars flowing into mobile sales in the developing countries have propelled the growth rate and growth prospects for mobile e-learning.

North America & Asia Pacific Online Education Market would Witness Market Growth

Online education in Asia Pacific has glimpsed an enhanced acceptance over a few years. It is an integral part of the colleges, schools, and even offices across Asia. One of the advantages of online education is that this kind of education model is efficiently scalable. The government is also allowing the universities to deliver fully online degrees, a change that could reshape the education industry in the country like India and China. Besides, the availability of high-speed internet and the advent of the 5G network in Asia-Pacific are delivering lucrative opportunities for market players to adopt innovative technologies.

Over the years, the increased penetration of the internet and the availability of low-cost smartphones has raised the number of online users in India. This has created a surge in demand for online education like K-12 education, vocational training, higher education in rural and urban areas. Similarly, the government in India is undertaking various digital initiatives such as ePathshala, which provides educational web resources for students, parents, teachers, researchers, and educators. Key players operating in the market include Coursera, Instructure Inc., Byju’s, Adobe Inc., and Alphabet Inc.

Follow the link for the full report with detailed TOC and list of figures and tables:  https://www.renub.com/online-education-market-p.php

Market Summary:

User Type – We have covered Global Online Education Market breakup by 3 viewpoints by- User Type (Academic (Higher Education, Vocational Training, K-12 Education and Others), Corporate (Large Enterprise and SMBs and Government)

Provider – Renub Research Report covers by provider in the 2 viewpoints (Services and Content)

Technology – Our Report has covered Global Online Education Market breakup by 6 Technology (Online e-learning, Learning Management System (LMS), Mobile e-learning, Rapid e-learning, Virtual classroom and Others)

Region – This Report covers by Region in the 5 viewpoints (North America (United States and Canada), Europe (United Kingdom, Germany, France, Italy, Spain and Russia), Asia-Pacific (China, India, Japan, South Korea, Singapore and Australia), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), Middle East & Africa)

All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Coursera, Instructure Inc., Byju’s, Adobe Inc. and Alphabet Inc.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

Global Oncology Precision Medicine Market is expected to grow at a CAGR of 11.6% during 2021-2027

As per the latest report by Renub Research titled “Oncology Precision Medicine Market, Size, Global Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” the Global Oncology Precision Market Size will reach USD 64.66 Billion by 2027. Oncology precision medicine is an emerging trend in the healthcare industry that has been growing quickly in recent years. It makes the diagnosis of cancer and other diseases more accurate and evaluates the specific genetic makeup of their tumors to select the safest and most effective treatments for them. In cancer, precision medicine involves sampling DNA from patients’ tumors to determine the mutations or other genetic changes that drive their cancer. Physicians then may select a treatment for a particular patient’s cancer that best matches, or targets, the culprit mutations in the tumor DNA.

Likewise, some of the more common cancers where precision medicine is being used to help with treatment decisions include Lung Cancer, Stomach Cancer, Prostate Cancer, Liver Cancer, Oesophagus Cancer, Colorectal Cancer, Breast Cancer, r, cervical cancer, Kidney Cancer, and Bladder Cancer. Notwithstanding, the existing oncology precision medicine market is preferred by multiple factors, including several government initiatives, rising cancer incidences, and death rates, coupled with the general population’s growing awareness about molecular-level diagnosis and treatment. Besides, the increasing number of advancements in molecular diagnostics, increasing FDA approvals for such precision medicine-based oncology drugs, enhancing focus on research and development activities by crucial healthcare companies also led to market expansion. Furthermore, the development of newer therapeutic approaches, including gene therapy for cancer treatment and a rising number of patients undergoing predictive diagnosis, will propel the market growth.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=oncology-precision-medicine-market-p.php

COVID-19 Impact on Oncology Precision Market

COVID-19 has impacted the oncology precision medicine market. This impact was mainly due to disturbance of the supply chain and lockdowns imposed in many countries. Nevertheless, as the lockdowns were raised and supply was restored, the market has recovered quickly. As precision medicine deals majorly with fatal disorders like cancer involving life-saving drugs, the COVID-19 pandemic is poised to impact the market during the assessment period. Majorly for individuals living with cancer, the pandemic posed a unique set of challenges. The pandemic has certainly hindered surgeries and testing on biopsy tissue and has also impacted cancer patients’ ability to receive provider-administered drugs. Thus, the volume of oncology precision drugs and services declined notably in 2020.

Hospital end-users accounted for the largest share of the global oncology precision medicine market

On the basis of end-user, the global oncology precision medicine market is categorized into Hospitals, Diagnostic Centers, Research & Academic Institutes, and Others. The hospital’s segment accounted for the most significant market. The large share of this segment is primarily attributed to the rising number of tertiary/specialty care hospitals, rising incidence of cancer diseases, growing healthcare infrastructure, increasing demand for quality healthcare, and shift towards personalized/precision medicine. As per our research findings, Worldwide oncology precision medicine market was USD 33.40 Billion in 2021

North Americans raise oncology precision medicine production:

Geographically, North America is leading the oncology precision medicine market. The number of cancer patients in North America is growing notably. According to the (ACS) American Cancer Society, cancer is the leading reason of death in Canada and the second leading cause of death in the U.S. In U.S, about 1.8 million new cancer cases were diagnosed in 2020. High awareness in the region regarding precision medicine and increasing demand for personalized cancer treatment will drive the industry revenue in the region. The level of medical procedures, such as radiation, chemotherapy, and immunotherapy required, will depend upon the stage and type of cancer. Precision medicines play an essential role in helping physicians determine a suitable treatment plan based on the current genetic mutations of the patient.

Similarly, oncology precision medicine treatments have gained momentum among clients in the Asia-Pacific region in the past few years. They utilize advanced technologies and innovative methods to create personalized medicines that cater to patients’ medical needs. The global precision medicine market players are Eli Lily and Co., F. Hoffmann – La Roche Ltd, Novartis AG, Bristol–Myers Squibb and AstraZeneca.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/oncology-precision-medicine-market-p.php

Market Summary:

  • Product Type – We have covered Global Oncology Precision Medicine Market breakup by 2 viewpoints by- product type (Diagnostics and Therapeutics)
  • Indication – Renub Research Report covers by Indication in the 11 viewpoints (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Oesophagus Cancer, Cervical Cancer, Kidney Cancer and Bladder Cancer)
  • End Users – Our Report has covered Global Oncology Precision Medicine Market breakup by 4 End Users (Hospitals, Diagnostic Centers, Research & Academic Institutes and Others)
  • Region – This Report covers by Region in the 5 viewpoints (North America, Europe, Asia Pacific, Latin America and the Middle East & Africa)
  • All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Eli Lily and Co., F. Hoffmann – La Roche Ltd, Novartis AG, Bristol–Myers Squibb and AstraZeneca.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

Global Pediatric Vaccine Industry to register a CAGR of 4.4% during the forecast period of 2021-2027

As per the latest report by Renub Research titled “Pediatric Vaccines Market, Size, Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” Pediatric Vaccines Market Size was US$ 47.8 Billion by 2021. The vaccines administered to stop children from contracting several infectious diseases and non-infectious are pediatric vaccines. These vaccines are heat-killed or inactivated viruses that lose their pathogenicity, i.e., the ability to cause disease. Additionally, these inactivated antigens can stimulate the immune system to produce antibodies against the infected virus.

Besides, pediatric vaccines are distributed to a child in its pediatric age, from 0 –18 years. Vaccines are commonly given to prevent children from diseases transferred through seasonal variations, infections, and even though unhygienic areas. Depending upon the disorder, the vaccines are administered at regular intervals. World Health Organization (WHO) has designed a standard immunization program to have desired time interval between vaccines doses.

Pediatric Vaccine Growth Factors

Globally, the growing prevalence of chronic disorders such as diphtheria, tuberculosis, and pneumonia in the age of 15 years and downward will contribute to the development of the pediatric vaccines industry. According to WHO, globally around 5 billion severe illnesses and 0.5 billion deaths yearly. As immunization plays a vital role in modern medicine, several international programs for children may vary based on the disease. Nevertheless, these programs are primarily driving the demand in the pediatric vaccines market. Further, the global pediatric vaccines market is driven by factors such as the global initiative undertaken by key players to develop innovative vaccines and increase government support.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=pediatric-vaccines-market-p.php

The Combos Vaccine Segment is to Grow at a Significant Rate:

Based on Vaccine Types, the Pediatric Vaccine industry includes Influenza, MMR (Measles, Mumps, and Rubella Vaccine), Pneumococcal, Meningococcal, Hepatitis, DTaP, mophilus Influenzae Type B (HIB), Combos (Combination), Polio, Rotavirus, Varicella and Coronavirus (COVID-19). Infections are always a leading cause of mortality and morbidity in children under 5 years of age, most of which can be stopped by vaccination. However, too many vaccines are to be administered, increasing the cost of immunization and visits to the pediatrician. Combination vaccines can answer these problems until developing a single vaccine containing all the possible antigens.

Additionally, combination vaccines such as the 5-in-1 and the MMR have been developed to help reduce the number of injections needed. Even so, children and babies often receive several vaccines at once. For example, a 2-month-old baby will simultaneously obtain the 5-in-1, PCV, Rotavirus, and MenB vaccines. Moreover, as per our Report statistics, the number of infants vaccinated from Combination Vaccines across the world was 163.52 Million in 2021, and it increased appreciably to 339.04 Million by 2027.

COVID-19 Impact on Global Pediatric Vaccines Market:

The COVID-19 has upended the lives of children and their families. Therefore, amidst the pandemic, the global market for Pediatric vaccines dropped in 2020 as most healthcare personnel were busy in COVID-19 management. The pandemic naturally affected the routine immunization programs and campaigns conducted globally in developing and developed countries. The UNICEF and World Health Organization (WHO) warned of an alarming drop in the number of children receiving life-saving vaccines worldwide. This is due to troubles in the delivery and uptake of immunization services caused by the COVID-19 pandemic.

Regardless, Influenza vaccination rates have gone up considerably during the pandemic due to push from health experts/health departments and the extension of different government programs that provide free vaccination against the flu. Also, growing awareness among the public about the higher risk of getting infected with COVID-19 if the flu weakens the immune system is another factor contributing to the uptake of flu vaccines.

Key Players:

The pediatric vaccines industry consists of several major players, including GlaxoSmithKline, Plc, Merck & Co., Sanofi Pasteur’s, Pfizer, Inc.’s, CSL Limited. The companies enforce specific strategic initiatives like new product launches, mergers, acquisitions, and partnerships, which help them strengthen their market position.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/pediatric-vaccines-market-p.php

Market Summary:

  • Vaccine Types – We have covered Global Pediatric Vaccines Market & Numbers of Population breakup by 2 viewpoints by Vaccine Type (Influenza, MMR (Measles, Mumps, and Rubella Vaccine), Pneumococcal, Meningococcal, Hepatitis, DTaP, mophilus Influenzae Type B (HIB), Combos (Combination), Polio, Rotavirus, Varicella and Coronavirus (COVID-19))
  • Regions – We have covered all the 5 Regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa in this report
  • All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) GlaxoSmithKline, Plc, Merck & Co., Sanofi Pasteur’s, Pfizer, Inc.’s, CSL Limited.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

Global Dialysis Market Size registered a CAGR of 5.7% from 2021 to 2027

As per the latest report by Renub Research titled “Global Dialysis Market, Size, Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” Global Dialysis Market Size was USD 92.5 Billion in 2021. Worldwide, dialysis is an essential and life-saving treatment for chronic renal failure (CRF), kidney diseases, end-stage renal disease (ESRD). Dialysis is a treatment that purifies blood using a machine. It utilizes special equipment to remove excess water and waste products from the blood. In this procedure, the blood is filtered, excess toxins and fluid are removed, and electrolyte balance is restored. Dialysis is carried out in two ways: peritoneal and hemodialysis dialysis. Both perform the usual filtering of waste kidney functions and excess fluid from the blood.

Key Factors Driving the Growth of the Dialysis Industry:

Dialysis market growth is driven by the increasing diabetic population, higher prevalence among ageing population, and rising cases of ESRD are anticipated to drive the market. Further, an increase in the advancement of home-based services and the number of treatment centers are the aspects attributing toward the dominance of the services segment. Moreover, improved reimbursement policies for renal treatment by private and public institutions are encouraging the expansion of the market at a remarkable rate. For instance, in 2020, according to the End-Stage Renal Disease (ESRD) PPS final rule, the Centers for Medicare & Medicaid Services (CMS) to pay around US$ 10.3 billion in Medicare reimbursements to about 7,000 ESRD providers for the costs of delivering renal hemodialysis services.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=global-dialysis-market-p.php

How Coronavirus Affected the Dialysis Industry

Besides, the COVID-19 pandemic had a moderate impact on the market. COVID-19 is majorly a respiratory disease, but it has also been shown to impact kidneys, damaging the organ to cause acute renal infection (AKI). The pandemic also disrupted the supply chain operations and affected the availability of hemodialysis, consumables for peritoneal dialysis, and essential medicines, leading to a drop in dialysis procedures performed in several dialysis centers. Due to such adverse scenarios, the overall impact of the COVID-19 pandemic on the market is to be substantial.

Hemodialysis to Account for Maximum Share

Based on type, the dialysis market is bifurcated into hemodialysis and peritoneal dialysis. The hemodialysis segment is a significant contributor to the dialysis market growth. Hemodialysis helps balance minerals such as sodium, calcium, and potassium that aids in decreasing blood pressure. Routine hemodialysis is conducted in a hospital, dialysis outpatient facility, or a dedicated stand-alone clinic that surges the market demand. Also, the growing prevalence of chronic kidney diseases across the globe will boost the acceptance rate of hemodialysis among the patient population base. Hemodialysis is classified into short daily, conventional hemodialysis, hemodialysis, and nocturnal hemodialysis.

In terms of end-users, the dialysis market is segmented into in-center and home dialysis. Dialysis treatments centers accounted for the significant market, attributable to the favorable reimbursement provided by renal facilities. Most patients prefer to obtain dialysis treatments through services delivered by dialysis centers making them the most significant contributor to the global dialysis market. Regardless, a rise in awareness and surge in demand for home healthcare among dialysis patients is predicted to make home dialysis the fastest-growing segment during the forecast period. Home dialysis offers several benefits, including reducing travel expenses, improved quality of life, flexibility, and accessible patient mobility.

Rising Dialysis Cases in the North American Region will Fuel the Industry’s Progression:

Amongst regions worldwide, North America is projected to lead the dialysis market owing to the higher usage of dialysis therapy to treat several end-stage renal diseases and chronic kidney diseases. The high prevalence of CKD and ESRD in the U.S. and Canada, coupled with higher treatment rates in these countries, are the pivotal factors estimated to boost the expansion of the market during the forecast period. Further, the North American region is projected to see growth attributable to the growing incidence of coronavirus infections and succeeding renal failures. Likewise, the Asia-Pacific region is anticipated to witness the growth in dialysis market during the coming year, which is attributed to a low rate of organ transplantation, surge in the incidence rate of kidney failure, and advancement in healthcare expenditure.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/global-dialysis-market-p.php

Competitive Landscape

The prominent players operating in the dialysis market include Baxter International Inc, Fresenius Medical Care, DaVita Inc, Asahi Kasei Corporation, and Medtronic Plc. These variant market participants are undertaking various progressive strategies to capture a higher revenue share in this dialysis market. Several development strategies enforced by foremost market players have helped them maintain a strong position in the industry.

Market Summary:

  • Type – We have covered Global Dialysis Market breakup by 2 viewpoints by Type (Hemodialysis, Peritoneal dialysis)
  • Product & Services – Renub Research Report covers by Product & Services in the 4 viewpoints (Services, Equipment, Consumables, and Drugs)
  • End-Users – Our Report has covered Global Dialysis Market breakup by end-users 2 viewpoints (In-center dialysis, Home dialysis)
  • Regions – Global Dialysis Market has covered by Region 5 viewpoints (North America, Europe, Asia Pacific, South America, Middle East and Africa)
  • All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Baxter International Inc, Fresenius Medical Care, DaVita Inc, Asahi Kasei Corporation, and Medtronic Plc.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch